文献速递放疗物理与技术姑息放疗与转移瘤

再程放疗专项医学物理会诊:近3000例治疗的经验总结

Reirradiation Special Medical Physics Consultations: Lessons Learned From Nearly 3000 Courses of Treatment.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2025-03-09

美国密歇根大学放疗科报告2017年建立的再程放疗专项医学物理会诊(SMPC)标准化工作流程及近7年2929例SMPC的经验。最常见的再程放疗部位为盆腔、脑和胸部,约三分之一患者既往治疗在外部机构进行;过去一年427例中82.2%满足机构再程放疗剂量限值。基于刚性图像配准的复合剂量计算在脑部最成功(93.8%),在腹部和盆腔最不成功(53.1%和51.2%)。

要点

  • 2017至2024年中完成2929例再程放疗SMPC,最常见部位为盆腔、脑和胸部。
  • 过去一年427例再程放疗中82.2%满足机构再程放疗剂量限值。
  • 刚性图像配准计算复合剂量在脑部成功率93.8%,腹部53.1%,盆腔51.2%。

核心结论

  • 基于近3000例再程放疗的7年经验,强调标准化再程放疗工作流程、改进累积剂量评估工具和标准化报告的必要性。

研究设计与样本

  • 回顾性分析密歇根大学放疗科2017年建立的再程放疗SMPC标准化工作流程,复习过去7年SMPC记录并对过去1年进行更深入回顾。

主要发现

  • 2017年至2024年中完成2929例SMPC,再程放疗最常见部位为盆腔、脑和胸部。
  • 约三分之一患者既往治疗在外部机构进行。
  • 过去一年427例再程放疗中82.2%满足机构再程放疗剂量限值。
  • 刚性图像配准计算复合剂量在脑部最成功(93.8%),在腹部和盆腔最不成功(53.1%和51.2%)。
  • 大多数再程放疗病例(80.3%)仅有单次既往治疗。

关键数值与推荐

  • 机构再程放疗剂量评估模板更新包括提高某些时间依赖性组织恢复因子、增删某些OAR、增加新的基于点和基于体积的剂量目标。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Reirradiation (reRT) has become increasingly prevalent due to an aging population and advancements in cancer detection and treatment. However, the field is still lacking standardized dosimetric evaluation methods and reRT workflows, which leads to difficulty in correlating clinical outcomes with delivered dose. This study reports on the implementation and evolution of a standardized reRT workflow in the Department of Radiation Oncology at University of Michigan, describing insights gained from nearly 3000 external beam reirradiation courses delivered since 2017. METHODS AND MATERIALS: A systematic workflow for reRT special medical physics consultations (SMPCs) was established in 2017. Patient SMPC records from the past 7 years were reviewed, with an additional more in-depth review of the past 1 year, to report on course characteristics including treatment sites, where prior treatment was delivered (in-house vs an outside institution), whether institutional dose limits were met and the associate reasoning, time intervals between RT, the type of dose summation method used (rigid image registration-based vs point dose-based), as well as the evolution of this workflow. RESULTS: Of the 2929 SMPCs conducted from 2017 to mid-2024, the most common treatment sites for reRT were the pelvis, brain, and thorax. About a third of patients had prior treatments at outside institutions. Of the 427 courses treated in the past year, institutional reirradiation dose limits were met in 82.2%. Rigid image registration was most successful for calculating composite dose in the brain (93.8% of cases) and least successful in the abdomen and pelvis (53.1% and 51.2%, respectively), and most reRT cases (80.3%) had a single prior course of treatment. Several updates were made to our institutional reRT dosimetric evaluation template, including increasing some time-dependent tissue recovery factors, adding and removing some OARs, and adding new point-based and volumetric dose objectives. CONCLUSIONS: On the basis of our 7 years of experience with nearly 3,000 courses of reRT, we highlight the critical need for standardized reirradiation workflows, improved tools for cumulative dose assessment, and standardized reporting. These efforts will facilitate cross-institutional data sharing to enhance data-driven clinical decision-making and improve patient outcomes in reRT. As the prevalence of reRT rises, these efforts are vital for advancing safe and effective cancer care.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Paradis KC, Mayo C, Matrosic CK, et al. Reirradiation Special Medical Physics Consultations: Lessons Learned From Nearly 3000 Courses of Treatment. Int J Radiat Oncol Biol Phys. 2025. PMID: 40068779. doi:10.1016/j.ijrobp.2025.03.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。